The CRISPR/Cas System in Human Cancer

Martín Hérnan Bonamino1, Eduardo Mannarino Correia2

  • 1Instituto Nacional do Câncer, Coordenação de Pesquisa, Rio de Janeiro, RJ, Brazil. mbonamino@inca.gov.br.

Insights

CRISPR gene editing technology simplifies genome manipulation in oncology research. This review highlights its applications in biological screenings, model generation, and developing novel cancer treatments.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • CRISPR technology offers a revolutionary approach to genetic editing.
  • Its application has significantly impacted cancer research, from basic science to clinical applications.

Purpose of the Study:

  • To review the diverse applications of CRISPR technology in oncology.
  • To explore its role in advancing cancer knowledge and treatment strategies.

Main Methods:

  • In vitro and in vivo biological screenings using CRISPR.
  • Generation of cellular and animal models for cancer research.
  • Development of novel CRISPR-derived tools for cancer studies.

Main Results:

  • CRISPR facilitates simple, fast, and cost-effective genome manipulation.
  • The technology enhances the understanding of cancer biology.
  • It provides new avenues for developing improved cancer therapies.

Conclusions:

  • CRISPR gene editing is a transformative tool in oncology research.
  • It accelerates discovery and offers promising solutions for cancer treatment.
  • Continued innovation in CRISPR technology will further advance cancer care.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
64
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.4K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
59
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.7K